Novartis sells $2.1B in bonds to increase access to its drugs in disadvantaged countries

Swiss pharma giant Novartis recently garnered about $2.1 billion from investors by selling bonds linked to its promises to make its treatments more accessible in lower-income countries, according to STAT.